FDA approves Alzheimer's drug from Biogen, against expert advice

To ensure delivery to your inbox add email@mail.nbcnews.com to your contacts | View in browser Add NBC News to your contacts Unsubscribe from this email

Jun 07, 2021 FDA approves Alzheimer's drug from Biogen, against expert advice The Food and Drug Administration approved an Alzheimer's drug on Monday, the first new drug for the disease in 18 years. The announcement comes after an independent advisory panel urged the agency to reject the drug, called aducanumab, warning that the treatment hadn't been shown to help slow the progression of the disease. Read More Get the NBC News Mobile App Follow NBC News Check out all of NBCNEWS Newsletters here. Update Preferences | Unsubscribe | Contact | Privacy Update Preferences Unsubscribe Contact Privacy